Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-06-29

FDA Approved: DESVENLAFAXINE — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approves Alembic Pharmaceuticals' original application for desvenlafaxine succinate (desvenlafaxine) as a generic antidepressant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desvenlafaxine (Desvenlafaxine)

Snippet

ORIG AP for DESVENLAFAXINE (DESVENLAFAXINE SUCCINATE)